This Is What Whales Are Betting On Regeneron Pharmaceuticals
Portfolio Pulse from Benzinga Insights
A significant bullish stance has been taken on Regeneron Pharmaceuticals (NASDAQ:REGN) by a large investor, as indicated by a large position in the company's options. The sentiment among these big-money traders is split 50-50 between bullish and bearish. The price target for Regeneron Pharmaceuticals, based on the volume and open interest of these contracts, ranges from $710 to $1000. Several financial institutions have maintained positive ratings on Regeneron, with price targets ranging from $820 to $950.
August 10, 2023 | 3:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
A large investor has taken a bullish stance on Regeneron Pharmaceuticals, with a price target ranging from $710 to $1000. This could potentially drive the stock price up in the short term.
The bullish stance taken by a large investor, as indicated by a significant position in the company's options, suggests a positive outlook for the company. This, combined with the positive ratings maintained by several financial institutions, could potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100